Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With ARDS

Clinical trial NCT05238532 · WITHDRAWN

Trial details

NCT number: NCT05238532
Sponsor: GC Cell Corporation
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome

Start date: 2022-01-26
Primary completion: 2023-02-22
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.